Story perspectives

Health Officials Warn of Rising Counterfeit Weight Loss Drugs

10/10/2025

41 5

Summary

Story summary

Health officials in the U.S. and the UK are alarmed by a rise in counterfeit GLP-1 weight loss medications sold online.
The U.S. Food and Drug Administration (FDA) warns that unapproved versions, often marketed as "no prescription needed," can pose serious health risks.
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) states that purchasing unlicensed medicines is illegal and can result in severe consequences.
Officials urge consumers to obtain medications through registered pharmacies to avoid dangerous counterfeit products, especially with the upcoming rollout of Eli Lilly's orforglipron.

1 of 1

Story summary

Health officials in the U.S. and the UK are alarmed by a rise in counterfeit GLP-1 weight loss medications sold online.
The U.S. Food and Drug Administration (FDA) warns that unapproved versions, often marketed as "no prescription needed," can pose serious health risks.
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) states that purchasing unlicensed medicines is illegal and can result in severe consequences.
Officials urge consumers to obtain medications through registered pharmacies to avoid dangerous counterfeit products, especially with the upcoming rollout of Eli Lilly's orforglipron.